First NanoMed Focus Group Event to Examine Role of Nanotechnology in Clinical Practice 8th July 2010, Royal Free Hospital, Hampstead, London
The Nanotechnology Knowledge Transfer Network (NanoKTN), one of the UK’s primary knowledge-based networks for Micro and Nanotechnologies, is pleased to announce the first event from its NanoMed focus group. The event will examine areas where nanotechnology is already improving clinical practice and also where the technology will be impacting healthcare in the near and distant future.
The NanoKTN’s NanoMed focus group has been established to develop industry clinical partnerships, promote the benefits of nanomedicine in the clinical community, identify key areas of unmet medical needs that nanotechnology can address, and ensure clinicians are engaged at the earliest stages of product development.
Dr Mike Fisher, Theme Manager – Healthcare & Life Sciences, NanoKTN explains: "This meeting will be the first event of the NanoMed focus group and will cover topics such as cardiovascular disease and cancer treatment, focussing on the opportunities that nanotechnology offers to improve patient care."
The potential of nanotechnology in the medical sector cannot be underestimated. However considering the number and size of players in the market, it is still a fledgling industry. Market projections into 2021 show strong growth for nanotechnology-based applications in pharmaceuticals, diagnostics and medical devices.
Key speakers at the event include Prof. Alexander Seifalian, Professor of Nanotechnology & Tissue Repair in Surgery, University College London, Prof. Shervanthi Homer-Vanniasinkam, Leeds General Infirmary, who will be delivering a presentation on Nanotechnology in cardiovascular disease, and Dr Sarwat Rizvi from the Royal Free Hospital who will discuss nanotechnology in breast cancer treatment.
The NanoMed conference takes place on the 8th July 2010 at the Royal Free Hospital, Hampstead, London. All stakeholders who are interested to learn more about how nanotechnology is being used to improve clinical practice and where the technology will be impacting healthcare in the near future are encouraged to register for the conference.
Attendance is free of charge, but registration is essential. Please complete the booking form found at www.nanoktn.com and return to Natasha Taylor by email: email@example.com by fax to 01740 625 792.
Membership to the NanoKTN and NanoMed focus group is free of charge. For more information about how to join and for a full list of speakers and presentation abstracts, please visit www.nanoktn.com.
Established by the Technology Strategy Board, the NanoKTN is managed by Centre for Process Innovation Ltd, a leading technology development and consulting company.